Producing cGMP biopharmaceutical products requires controlled, consistent performance of the manufacturing process. cGMP also requires controlled, consistent performance of analytical test methods.

From small private wells producing around 100 barrels a day to the large bore wells producing more than 40 times that volume, gas and oil and for fuel are produced in nearly every corner of the globe.

Bioassay variability can pose significant challenges due to laboratory conditions, instrumentation, analytical software, cell culture performance and reagent sourcing. These inconsistencies can impact ...